Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Change in Intangibles: 2018-2024

Historic Change in Intangibles for Ultragenyx Pharmaceutical (RARE) over the last 4 years, with Dec 2024 value amounting to $12.5 million.

  • Ultragenyx Pharmaceutical's Change in Intangibles rose 50.00% to $15.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $30.0 million, marking a year-over-year decrease of 25.42%. This contributed to the annual value of $12.5 million for FY2024, which is 400.00% up from last year.
  • Ultragenyx Pharmaceutical's Change in Intangibles amounted to $12.5 million in FY2024, which was up 400.00% from $2.5 million recorded in FY2023.
  • In the past 5 years, Ultragenyx Pharmaceutical's Change in Intangibles ranged from a high of $30.0 million in FY2022 and a low of $2.5 million during FY2023.
  • Over the past 3 years, Ultragenyx Pharmaceutical's median Change in Intangibles value was $12.5 million (recorded in 2024), while the average stood at $15.0 million.
  • As far as peak fluctuations go, Ultragenyx Pharmaceutical's Change in Intangibles slumped by 91.67% in 2023, and later surged by 400.00% in 2024.
  • Over the past 3 years, Ultragenyx Pharmaceutical's Change in Intangibles (Yearly) stood at $30.0 million in 2022, then crashed by 91.67% to $2.5 million in 2023, then soared by 400.00% to $12.5 million in 2024.